Alexion Pharmaceuticals (ALXN +3%) extends gains after its solid Q4 beat, and Baird raises the...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion Pharmaceuticals (ALXN +3%) extends gains after its solid Q4 beat, and Baird raises the stock to Outperform with a target of $100 from $72. The firm thinks shares will continue to work higher so long as estimates are increasing and clinical events remain positive, seeing sizable upside to consensus and several meaningful pipeline readouts this year.